How much does Seleniso cost in China and whether patients can accept it?

Selinexor (Selinexor) is a compound that plays an important role in the treatment of certain cancers and is widely used in clinical trials and treatments. In China, the price of Seleniso may vary depending on region and supply channel. Generally speaking, prices may be affected by factors such as production costs, market demand, sales pricing, and distribution channels.

Selinisol is an oral anticancer drug that is a selective nuclear transport inhibitor. It inhibits the Karyopherin β1 protein in the nucleus and prevents key proteins in cancer cells from entering the cytoplasm from the nucleus, thereby interfering with the viability of cancer cells. Selinisol may be used in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy; or in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma. Selinisol is also indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL caused by follicular lymphoma, who have received at least 2 systemic therapies.

For patients, the price of a drug is an important consideration. The price of each box of Seleniso's original drug, which is domestically marketed and included in medical insurance, may be more than more than RMB 20,000. Patients who meet the indications can use medical insurance for reimbursement. Selinisol may be considered an effective treatment option for some patients with specific types of cancer who undergo rigorous evaluation and meet guidelines for use. However, each patient's situation is different, and doctors will evaluate whether the drug is suitable for use based on the patient's specific situation, taking into account its efficacy, side effects, safety, and economic burden.